You may want to consider taking a Q10 supplement

Statins do more than lower your cholesterol. They have an array of side effects but you can effectively counteract them by taking coenzyme Q10 together with your drug.

Has your physician told you to take cholesterol-lowering statins? Well, it has to be said that these drugs are highly effective for lowering cholesterol. What you may not know, however, is that statins also lower levels of coenzyme Q10, a vital substance which all your cells need to produce energy. Coenzyme Q10 and cholesterol are synthesized in the liver and share the same biochemical pathway, and statins work by blocking this pathway. When levels of coenzyme Q10 go down, you risk a number of side effects that occur when the body's cells suddenly produce too little energy to function normally.

it’s the ultimate and essential “brainwash”

Groundbreaking research reveals that the human brain is detoxified during our sleep. On the other hand, toxins accumulate in the brain if we suffer from sleep disturbances, increasing our risk of dementia, Alzheimer’s disease, stroke, and numerous other conditions. If you are not helped by the most common guidelines for better sleep, supplementing with the “sleep hormone” melatonin may be an obvious solution that even offers plenty of positive “side effects.”

Researchers have found that sufferers of non-alcoholic fatty liver disease (NAFLD) can protect themselves by taking the vitamin-like substance coenzyme Q10.

Non-alcoholic fatty liver disease is a chronic liver disorder that involves inflammation of the liver and may worsen through a four-stage progression that may eventually lead to cirrhosis and liver cancer. The condition, which is characterized by a build-up of fat in the liver cells and typically affects people who are diabetic or overweight. There is currently no medical treatment for NAFLD but science has found that the vitamin-like substance coenzyme Q10 may be able to improve the liver’s fat metabolism and reduce the inflammation.

Texting, reading emails and surfing the net in bed is bad for your health. The blue light that is emitted from the devices inhibits sleep and work performance, according to scientific experts.

Many people bring their mobile phones, laptop computers, or tablets to bed to text, read emails, or surf the net. This, scientists say, is bad for one’s health. The blue light that is emitted from the screens affects human biology in a way that inhibits sleep and work performance.

Studies have shown that sufferers of recurrent migraine headaches may benefit from supplements of the vitamin-like substance coenzyme Q10.

Migraines may be caused by a number of things and cannot be cured as such. A variety of medications have been designed specifically to treat migraines and, in addition, certain drugs that are commonly used to treat other disorders may even help relieve or prevent migraines. However, an increasing number of migraine sufferers seek more natural ways to deal with their recurrent migraine attacks and one remedy that has attracted a substantial amount of interest is the vitamin-like compound coenzyme Q10.

Even at very high intake levels, vitamin D does not appear to cause toxicity, an American study reveals.

Some experts have warned people against taking vitamin D in doses that exceed the recommended daily allowance (RDA), claiming that excess vitamin D may lead to problems such as hypercalcemia, a condition characterized by elevated blood calcium levels that may cause weakness, kidney stones, and brain and heart disturbances. However, a study conducted by Mayo Clinic researchers has shown that vitamin D toxicity is not really an issue. The team of scientists analyzed blood data collected in the period 2002-2011 from patients in the Rochester Epidemiology Project and made some interesting observations.

Researchers have found that individuals who are genetically prone to low vitamin D status have an increased risk of multiple sclerosis.

A team of researchers from McGill University, Canada, has found a link between decreased vitamin D status and increased risk of multiple sclerosis (MS). In their study, which is published in PLOS Medicine, they compared data from thousands of participants with and without MS. As part of their research they looked at how genetic factors affected vitamin D levels in the participants. The researchers found that those people who were genetically prone to low vitamin D status were at least twice as likely to have MS. To explain their observations in more simple terms, when you increase a person's circulating levels of 25OHD (biologically active vitamin D) by 1.5-fold, it decreases their risk of developing MS by 50%.

American scientists have demonstrated that measurements of vitamin D levels in patients with early stages of sclerosis may predict how fast the disease will progress. If levels are low it may be a sign of faster disease progression and also a sign that this development may be slowed down if the patients increase their vitamin D intake.

The study is published in the science journal JAMA Neurology and was carried out on 465 patients from more than 20 different countries. The results showed that patients with highest levels of vitamin D had fewer brain lesions (57%) and less recurrence (75%) compared with the group that had low vitamin D levels.